Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

v3.20.1
CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Revenues:    
Total revenues $ 1,336 $ 945
Operating expenses:    
Cost of goods sold 171 304
Research and development 2,277 1,844
Selling, general and administrative 3,114 3,082
Total operating expenses 5,562 5,230
Loss from operations (4,226) (4,285)
Other expense:    
Interest expense, net (222) (246)
Non-cash loss on changes in the fair value of warrants (923) 0
Other income (expense), net (213) 14
Other expense, net (1,358) (232)
Net loss and comprehensive loss $ (5,584) $ (4,517)
Basic and diluted net loss per common share $ (0.07) $ (0.34)
Weighted average shares used in computing basic and diluted net loss per common share 82,641 13,217
License revenue    
Revenues:    
Total revenues $ 0 $ 313
Product revenue    
Revenues:    
Total revenues 210 317
Grant revenue    
Revenues:    
Total revenues $ 1,126 $ 315